Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-target vs Full-target Resection in Recurrent Nasopharyngeal Carcinoma
NCT05877872Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- May 2023
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Overall Survival at 3 years. Started May 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05877872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05877872.